Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19
Short communication
Published on
Journal: Biomedicine & pharmacotherapy = Biomédecine & phar [Category] SARS, 신약개발, 치료제,
Journal: Biomedicine & pharmacotherapy = Biomédecine & phar [Category] SARS, 신약개발, 치료제,
[키워드] a potassium ion channel in heart
ACCdrug accumulation
accumulate
accumulating
acid/base ionisation constant
addition
antiviral activity
antiviral effects
antivirals
applied
approach
assessments
available data
C-C chemokine receptor type 5
CADcationic amphiphilic drug
cationic amphiphilic drug
CCR5C-C chemokine receptor type 5
cells
clinical trial
combating
Compound
Coronaviruses
COVID-19
COVID-19 pandemic
criteria
disease
displaying
distribution coefficient of non-charged species of compound between octanol and water
drug
drug accumulation
drugs
endoplasmatic reticulum
endosomal pathway
endosome
Endosomes
ERendoplasmatic reticulum
Evidence
example
help
hERGhuman Ether-à-go-go-Related Gene
highest
human Ether-à-go-go-Related Gene
identify
in silico
inherent
interfere
knowledge
logPdistribution coefficient of non-charged species of compound between octanol and water
lysosome
Lysosomes
membrane
molecular
outbreak
Patient
pharmacokinetic
Phospholipidosis
physicochemical
pKaacid/base ionisation constant
PLDphospholipidosis
QSARquantitative structure activity relationship
quantitative structure activity relationship
Registered
reported
Spread
Support
tested
Vdvolume of distribution
viral infection
volume of distribution
[DOI] 10.1016/j.biopha.2020.110582 [Article Type] Short communication
[DOI] 10.1016/j.biopha.2020.110582 [Article Type] Short communication